Pureos Bioventures is a venture capital fund, which invests exclusively in private innovative drug development companies, with a special emphasis on the next generation of biological drugs and drug formats. The fund’s portfolio companies are built on scientific excellence to develop therapies across a broad indication spectrum including oncology, immunology, ophthalmology, rare diseases, and neuroscience. Pureos has built a team with deep investment, operating and clinical expertise, that strives to impact patients’ lives by advancing innovative treatments for devastating diseases.
10
Total Investments
5
Portfolio Companies
-
Exits
1
Industries
General Information
Industries
Biotechnology
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About BB Pureos Bioventures
Recent Investments (10)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series A | •••••• | Oct 2025 | |
| Series D | •••••• | Nov 2024 | |
| Seed | •••••• | Jun 2024 | |
| Series C | •••••• | Apr 2023 | |
| Series A | •••••• | Apr 2023 | |
|
|
Series A | •••••• | Jun 2022 |
|
|
Spinout | •••••• | May 2022 |
|
|
Series B | •••••• | Jun 2021 |
|
|
Spinout | •••••• | Apr 2019 |
|
|
Series A | •••••• | Mar 2019 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.